RXO (NYSE:RXO) Price Target Lowered to $13.00 at Susquehanna

RXO (NYSE:RXO) had its price objective reduced by equities research analysts at Susquehanna from $18.00 to $13.00 in a report issued on Wednesday,Benzinga reports. The brokerage presently has a “negative” rating on the stock. Susquehanna’s price objective indicates a potential downside of 32.83% from the company’s previous close.

Several other research analysts also recently commented on the company. Stifel Nicolaus decreased their price objective on RXO from $27.00 to $24.00 and set a “hold” rating on the stock in a report on Thursday, February 6th. Deutsche Bank Aktiengesellschaft started coverage on RXO in a research report on Friday, March 7th. They issued a “hold” rating and a $19.00 price objective for the company. Wells Fargo & Company cut their target price on shares of RXO from $31.00 to $28.00 and set an “equal weight” rating on the stock in a report on Tuesday, January 7th. The Goldman Sachs Group dropped their price target on shares of RXO from $28.00 to $24.00 and set a “neutral” rating for the company in a research report on Thursday, February 6th. Finally, Truist Financial began coverage on shares of RXO in a research note on Thursday, March 13th. They set a “buy” rating and a $24.00 price objective for the company. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $25.33.

RXO Stock Up 1.6 %

Shares of NYSE:RXO opened at $19.36 on Wednesday. The firm has a fifty day moving average of $21.44 and a 200 day moving average of $25.25. RXO has a 52-week low of $17.50 and a 52-week high of $32.82. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.33 and a current ratio of 1.26. The firm has a market capitalization of $3.16 billion, a PE ratio of -9.13, a price-to-earnings-growth ratio of 4.55 and a beta of 1.67.

RXO (NYSE:RXO) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.06 EPS for the quarter, hitting the consensus estimate of $0.06. RXO had a negative net margin of 6.26% and a positive return on equity of 1.53%. As a group, research analysts anticipate that RXO will post 0.31 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Blue Trust Inc. raised its position in shares of RXO by 79.7% in the 4th quarter. Blue Trust Inc. now owns 1,150 shares of the company’s stock worth $27,000 after purchasing an additional 510 shares during the last quarter. Wilmington Savings Fund Society FSB purchased a new position in RXO in the third quarter worth about $28,000. Smartleaf Asset Management LLC increased its position in shares of RXO by 228.4% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,248 shares of the company’s stock valued at $30,000 after acquiring an additional 868 shares in the last quarter. Nomura Asset Management Co. Ltd. increased its position in shares of RXO by 68.7% during the third quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company’s stock valued at $39,000 after acquiring an additional 570 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. raised its holdings in RXO by 407.0% in the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,800 shares of the company’s stock worth $43,000 after acquiring an additional 1,445 shares during the last quarter. Institutional investors own 92.73% of the company’s stock.

About RXO

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.